David S. Knopman

Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.

Richard C. Mohs, David S. Knopman, R. Petersen et al. · PubMed · 1997 · 493 citations

Disease Cooperative Study, Neuropsychology, Cognitive Rehabilitation +22

Assessing the Temporal Relationship Between Cognition and Gait: Slow Gait Predicts Cognitive Decline in the Mayo Clinic Study of Aging

Michelle M. Mielke, Rosebud O. Roberts, Rodolfo Savica et al. · The Journals of Gerontology Series A · 2012 · 442 citations · Full text

MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment

Jennifer L. Whitwell, Maria M. Shiung, Scott A. Przybelski et al. · Neurology · 2007 · 355 citations · Full text

Effects of a γ-secretase inhibitor in a randomized study of patients with Alzheimer disease

Eric Siemers, Joseph F. Quinn, Jeffrey Kaye et al. · Neurology · 2006 · 294 citations

Csf Abeta, Neurochemical Biomarkers, Pharmacotherapy +19

DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment

Kejal Kantarci, R. C. Petersen, B. F. Boeve et al. · Neurology · 2005 · 251 citations · Full text